Tsinghua-affiliated AI pharmaceutical company Shui Mu Molecules selected for CCTV's 'Top 10 AI Startups in China'

Shui Mu Molecules, as the only AI pharmaceutical company in CCTV's 'Top 10 AI Startups in China', combines expert experience with large model capabilities through its conversational AI native platform ChatDD, driving innovative drug research and development. Its BioMedGPT-10B is the world's first open-source 10-billion parameter multimodal biomedical large model, which has released 45 OpenBioMed skill packages covering five major professional fields. The company drives innovative drug pipelines in autoimmune diseases and tumors through a dual-wheel drive model of platform and pipelines, achieving preclinical candidate drugs in seven months, which is 58%-80% faster than traditional methods.